Search Results - "Vila Méndez, María Luz"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial

    Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial by Vila Méndez, María Luz, Antón Sanz, Carmen, Cárdenas García, Alicia Del Rocío, Bravo Malo, Amparo, Torres Martínez, Francisco Javier, Martín Moros, José María, Real Torrijos, María, Vendrell Covisa, José Francisco Javier, Guzmán Sierra, Olga, Molina Barcena, Verónica, Viejo Pinero, Nuria, Fernández Díaz, Carlos, Arroyo Burguillo, Purificación, Blanco Gallego, Ana María, Guirao Sánchez, Carmen, Montilla Bernabé, Aránzazu, Villanueva Morán, María Del Pilar, Juárez Antón, Salvador, Fernández Rodríguez, Ángela, Somoza Calvo, María Ángeles, Cerrada, Ernesto Cerrada, Pérez Mañas, Gemma, Sánchez Calso, Antonio, Vallejo Somohano, Frida, Cauqui Díaz, Carmen, Viñas Fernández, Gloria, Molina París, Jesús, González Godoy, Marina, Lumbreras García, Gonzalo, Rosado Martín, Javier, Rodríguez Hernández, Aida, López Antúñez, Sara, Vázquez Perfecto, Gabriel, Marcello Andrés, María Concepción, Puente García, Nieves Marina, Gil, Carmen, Martínez, Ana, Soler López, Begoña

    Published in Journal of clinical medicine (24-12-2022)
    “…A 28-day randomized open-label multicenter study was conducted to assess the efficacy of bromhexine plus standard of care (SOC) (n = 98) vs. SOC alone (n = 93)…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    A randomized, double-blind study on the efficacy of oral domperidone versus placebo for reducing SARS-CoV-2 viral load in mild-to-moderate COVID-19 patients in primary health care

    A randomized, double-blind study on the efficacy of oral domperidone versus placebo for reducing SARS-CoV-2 viral load in mild-to-moderate COVID-19 patients in primary health care by Rabanal Basalo, Alejandro, Navarro Pablos, Mercedes, Viejo Pinero, Nuria, Vila Méndez, María Luz, Molina Barcena, Verónica, Montilla Bernabé, Aránzazu, Villanueva Morán, María del Pilar, Blanco Gallego, Ana María, Guirao Sánchez, Carmen, Juárez Antón, Salvador, Fernández Rodríguez, Ángela, Revuelta Puigdollers, María Luisa, Sarriá Sánchez, María Teresa, Martín Alegre, Carmen, Martínez Álvarez, Miguel Ángel, Mestre de Juan, María, Mielgo Salvador, Rebeca, Gijón Seco, María Teresa, Saníger Herrera, José Manuel, Rodríguez Jiménez, María Esther, Navas de la Peña, Begoña, Santa Cruz Hernández, Javier, Abad Esteban, Ana María, Díaz Martín, Rebeca, García Pérez, Laura, Herrero Vanrell, Paloma, Arias de Saavedra Criado, María Isabel, Vaquero Vinent, Alexandra, López Gómez, Verónica, Montegrifo Rentero, Víctor Manuel, Simón Miguel, Lucía, Campo Martos, Ignacio, Ortiz Zamorano, Silvia, Izquierdo Zamarriego, María Jesús, Vázquez Carrión, Izíar, López Valero, Rosa María, Gil, Carmen, Martínez, Ana, Soler López, Begoña

    Published in Annals of medicine (Helsinki) (12-12-2023)
    “…INTRODUCTIONThe clinical effect of domperidone against COVID-19 has been investigated in a double-blind phase III clinical trial (EudraCT number…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: